Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

Secretory Phospholipase A2s in Insulin Resistance and Metabolism

Kuefner MS.

Clinical Trial on Type 2 Diabetes, published in Front Endocrinol (Lausanne) (2021) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Front Endocrinol (Lausanne) (2021)
Reported sample size
—
Source database
Europe PMC
PMID
34512555
PMCID
PMC8429832
DOI
10.3389/fendo.2021.732726
Citations
16

Abstract (original English)

The phospholipases A 2 (PLA 2 ) superfamily encompasses enzymes commonly found in mammalian tissues and snake venom. Many of these enzymes have unique tissue distribution, function, and substrate specificity suggesting distinct biological roles. In the past, much of the research on secretory PLA 2 s has analyzed their roles in inflammation, anti-bacterial actions, and atherosclerosis. In recent studies utilizing a variety of mouse models, pancreatic islets, and clinical trials, a role for many of these enzymes in the control of metabolism and insulin action has been revealed. In this review, this research, and the unique contributions of the PLA 2 enzymes in insulin resistance and metabolism.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsHumansMiceInsulin ResistanceInflammationInsulinSnake VenomsEnergy MetabolismPhospholipases A2, Secretory

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research